Data as of Oct 24
| +0.16 / +0.60%|
The 8 analysts offering 12-month price forecasts for Sabra Health Care REIT Inc have a median target of 30.50, with a high estimate of 31.00 and a low estimate of 28.00. The median estimate represents a +13.05% increase from the last price of 26.98.
The current consensus among 9 polled investment analysts is to Buy stock in Sabra Health Care REIT Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.